• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

TELK:US

1.0800 USD 0.0100 0.93%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Telik Inc (TELK)

Open: 1.0800 Day's Range: 1.0000 - 1.0800 Volume: 5,164
Previous Close: 1.0700 52wk Range: 0.6802 - 2.1500 1-Yr Rtn: -9.99%

Stock Chart for TELK

No chart data available.
  • TELK:US 1.0000
  • 1D
  • 1M
  • 1Y
1.0700
Interactive TELK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TELK

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -1.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 15.05
Shares Outstanding (M) 13.93
30 Day Average Volume 16,719
Price/Book (mrq) 8.4179
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TELK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TELK

Telik, Inc. is a biopharmaceutical company that discovers, develops, and commercializes small molecule drugs to treat serious diseases. The Company's most advanced product development programs are for the treatment of cancer and diabetes.

J David HansenPresident/CEOGregory P HansonChief Financial Officer
Philip O LivingstonChief Science OfficerWolfgang W ScholzVP:Antibody Discovery
More Company Profile & Key Executives for TELK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil